Vanda Pharmaceuticals Inc. - VNDA
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 18
Latest filed: Aug 19, 2026
| Form | Count |
|---|---|
| 4 | 9 |
| 8-K | 5 |
| SCHEDULE 13G | 2 |
| SCHEDULE 13G/A | 2 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Aug 19, 2026 | SCHEDULE 13G | — | 0001104659-26-098866 | View |
| Aug 13, 2026 | SCHEDULE 13G | — | 0001167557-26-000170 | View |
| Aug 05, 2026 | 8-K | Aug 05, 2026 | 0001628280-26-053308 | View |
| Jun 08, 2026 | 4 | Jun 04, 2026 | 0001193125-26-261800 | View |
| Jun 08, 2026 | 4 | Jun 04, 2026 | 0001193125-26-261806 | View |
| Jun 08, 2026 | 4 | Jun 04, 2026 | 0001193125-26-261811 | View |
| Jun 08, 2026 | 4 | Jun 04, 2026 | 0001193125-26-261871 | View |
| Jun 08, 2026 | 4 | Jun 04, 2026 | 0001193125-26-261768 | View |
| Jun 08, 2026 | 4 | Jun 04, 2026 | 0001193125-26-261782 | View |
| Jun 08, 2026 | 4 | Jun 04, 2026 | 0001193125-26-261790 | View |
| Jun 05, 2026 | 8-K | Jun 04, 2026 | 0001628280-26-041298 | View |
| May 20, 2026 | 4 | May 18, 2026 | 0001802653-26-000003 | View |
| May 06, 2026 | 8-K | May 06, 2026 | 0001628280-26-031241 | View |
| Apr 29, 2026 | SCHEDULE 13G/A | — | 0002052113-26-000465 | View |
| Apr 24, 2026 | 4 | Apr 22, 2026 | 0002130896-26-000008 | View |
| Apr 22, 2026 | 8-K | Apr 22, 2026 | 0001628280-26-026642 | View |
| Apr 02, 2026 | 8-K | Mar 29, 2026 | 0001628280-26-023222 | View |
| Mar 27, 2026 | SCHEDULE 13G/A | — | 0000102909-26-002588 | View |